ArticleJournal for immunotherapy of cancer2022

C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer.

Niklas Klümper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.